IL212752D0 - An molecule directed against the ??-secretase cleavage site of amyloid precursor protein, and uses thereof - Google Patents

An molecule directed against the ??-secretase cleavage site of amyloid precursor protein, and uses thereof

Info

Publication number
IL212752D0
IL212752D0 IL21275211A IL21275211A IL212752D0 IL 212752 D0 IL212752 D0 IL 212752D0 IL 21275211 A IL21275211 A IL 21275211A IL 21275211 A IL21275211 A IL 21275211A IL 212752 D0 IL212752 D0 IL 212752D0
Authority
IL
Israel
Prior art keywords
uses
cleavage site
directed against
precursor protein
amyloid precursor
Prior art date
Application number
IL21275211A
Other versions
IL212752A (en
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US36134402P priority Critical
Priority to PCT/US2003/006388 priority patent/WO2003076455A2/en
Application filed by Univ Ramot filed Critical Univ Ramot
Publication of IL212752D0 publication Critical patent/IL212752D0/en
Publication of IL212752A publication Critical patent/IL212752A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0007Nervous system antigens; Prions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/64Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645Dendrimers; Multiple antigen peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77Internalization into the cell
IL212752A 2002-03-05 2011-05-08 Molecule directed against the ß-secretase cleavage site of amyloid precursor protein and uses thereof IL212752A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US36134402P true 2002-03-05 2002-03-05
PCT/US2003/006388 WO2003076455A2 (en) 2002-03-05 2003-03-04 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein

Publications (2)

Publication Number Publication Date
IL212752D0 true IL212752D0 (en) 2011-07-31
IL212752A IL212752A (en) 2014-01-30

Family

ID=27805031

Family Applications (3)

Application Number Title Priority Date Filing Date
IL16381203A IL163812D0 (en) 2002-03-05 2003-03-04 Immunizing composition and method for inducing an immune response against the -secretase cleavage site of amyloid precursor protein
IL16381204A IL163812A (en) 2002-03-05 2004-08-30 Immunizing composition, antigenic product and isolated antigenic peptide for inducing an immune response against beta-secretase cleavage site of amyloid the precursor protein
IL212752A IL212752A (en) 2002-03-05 2011-05-08 Molecule directed against the ß-secretase cleavage site of amyloid precursor protein and uses thereof

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL16381203A IL163812D0 (en) 2002-03-05 2003-03-04 Immunizing composition and method for inducing an immune response against the -secretase cleavage site of amyloid precursor protein
IL16381204A IL163812A (en) 2002-03-05 2004-08-30 Immunizing composition, antigenic product and isolated antigenic peptide for inducing an immune response against beta-secretase cleavage site of amyloid the precursor protein

Country Status (8)

Country Link
US (3) US7494655B2 (en)
EP (2) EP2292247A3 (en)
JP (3) JP2005532276A (en)
AU (1) AU2003225636A1 (en)
CA (1) CA2477675C (en)
ES (1) ES2392247T3 (en)
IL (3) IL163812D0 (en)
WO (1) WO2003076455A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1398019A1 (en) 2002-09-13 2004-03-17 Cognis France S.A. Method for protecting and modulating the dermal-epidermal junction
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
WO2005033278A2 (en) * 2003-09-30 2005-04-14 Ludwig Institute For Cancer Research In vivo efficacy of ny-eso-1 plus iscom
CA2585148A1 (en) * 2004-10-28 2006-05-04 Sanko Junyaku Co., Ltd. Method of examining alzheimer's disease and diagnostic reagent
CN101365462A (en) 2005-10-18 2009-02-11 星药股份有限公司 Microbicidal dendrimer composition delivery system
PL1940916T3 (en) 2005-10-25 2017-07-31 Starpharma Pty Limited Macromolecular compounds having controlled stoichiometry
DK1976877T4 (en) 2005-11-30 2017-01-16 Abbvie Inc Monoclonal antibodies to amyloid beta protein and uses thereof
EP2289909B1 (en) 2005-11-30 2014-10-29 AbbVie Inc. Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
EP1981512A4 (en) * 2006-01-20 2013-04-10 Starpharma Pty Ltd Modified macromolecule
EP1996209B1 (en) 2006-03-22 2015-11-04 Starpharma Pty Limited Contraceptive composition
US20090324554A1 (en) * 2006-07-21 2009-12-31 Ramot At Tel Aviv University Ltd. Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar or aggregates
CN101516969B (en) 2006-08-11 2013-07-03 星药股份有限公司 Targeted polylysine dendrimer therapeutic agent modified macromolecule 2
WO2008064401A1 (en) * 2006-11-28 2008-06-05 Alzhyme Pty Ltd Improved peptide composition
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2124952A2 (en) 2007-02-27 2009-12-02 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
EP2987859B1 (en) 2007-09-27 2018-08-08 Japan Tobacco Inc Factor involved in latent infection with herpesvirus, and use thereof
GB0720912D0 (en) * 2007-10-25 2007-12-05 Univ Cardiff Monoclonal Anitbody for APP
KR101397554B1 (en) * 2007-11-09 2014-05-21 재단법인서울대학교산학협력재단 Compositions and method for the diagnosis, prevention and treatment of Alzheimer's disease
MX2010006422A (en) 2007-12-11 2010-06-25 Glaxo Group Ltd Antigen binding proteins.
EP2379076B1 (en) 2008-12-23 2014-11-12 The Trustees of Columbia University in the City of New York Phosphodiesterase inhibitors and uses thereof
WO2009124119A2 (en) * 2008-04-01 2009-10-08 The Trustes of Columbia University in the City of New York Phosphodiesterase inhibitors and uses thereof
WO2009155538A1 (en) * 2008-06-20 2009-12-23 Merck & Co., Inc. Compositions and methods of depleting amyloid-beta peptides from cerebrospinal fluid to treat alzheimer's disease
TW201438738A (en) 2008-09-16 2014-10-16 Genentech Inc Methods for treating progressive multiple sclerosis
AU2009316326A1 (en) * 2008-11-24 2010-05-27 Ramot At Tel-Aviv University Ltd. Method for treating Parkinson' s disease using filamentous bacteriophage
WO2011031720A1 (en) * 2009-09-11 2011-03-17 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Bispecific nanobodies as a therapeutic for alzheimer's disease
CN102933601B (en) 2010-04-15 2016-06-08 Abbvie公司 Amyloid beta is in conjunction with albumen
EP3533803A1 (en) 2010-08-14 2019-09-04 AbbVie Inc. Amyloid-beta binding antibodies
WO2015199247A1 (en) * 2014-06-27 2015-12-30 日本たばこ産業株式会社 Method for diagnosing, treating, or preventing mood disorder
CN106349334A (en) * 2015-07-15 2017-01-25 韩震 Polypeptide compound and preparation method and application thereof

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376861A (en) 1976-06-23 1983-03-15 The Dow Chemical Company Method for preparing 2-alkenyl-2-oxazolines
US4289872A (en) 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4600535A (en) 1982-02-12 1986-07-15 The Dow Chemical Company Cyclic peptides
US4517122A (en) 1982-02-12 1985-05-14 The Dow Chemical Company Cyclic peptides
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4515920A (en) 1984-04-30 1985-05-07 The Rockefeller University Synthesis of peptides and proteins
JPH0373280B2 (en) 1984-08-15 1991-11-21 Shingijutsu Kaihatsu Jigyodan
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (en) 1984-12-04 1986-06-21 Teijin Ltd Expression of hybrid antibody gene
US4599400A (en) 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
US5268164A (en) 1990-04-23 1993-12-07 Alkermes, Inc. Increasing blood-brain barrier permeability with permeabilizer peptides
DE69133372T2 (en) * 1990-06-15 2005-02-24 Scios Inc., Sunnyvale Transgenic, non-human mammalian animal showing the amyloid-forming pathology of Alzheimer's disease
US5222982A (en) 1991-02-11 1993-06-29 Ommaya Ayub K Spinal fluid driven artificial organ
US5441870A (en) * 1992-04-15 1995-08-15 Athena Neurosciences, Inc. Methods for monitoring cellular processing of β-amyloid precursor protein
US5580563A (en) 1992-05-01 1996-12-03 Tam; James P. Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
US5716614A (en) 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
US6221645B1 (en) 1995-06-07 2001-04-24 Elan Pharmaceuticals, Inc. β-secretase antibody
EP0871720A2 (en) 1995-06-07 1998-10-21 Athena Neurosciences, Inc. Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition
US5744346A (en) 1995-06-07 1998-04-28 Athena Neurosciences, Inc. β-secretase
US5719867A (en) 1995-06-30 1998-02-17 Scientific-Atlanta, Inc. Plural telephony channel baseband signal demodulator for a broadband communications system
WO1998021589A1 (en) 1996-11-15 1998-05-22 The Trustees Of The University Of Pennsylvania Screening for modulators of amyloid processing
PT1005368E (en) 1997-03-10 2009-11-19 Coley Pharm Gmbh Use of nucleic acids containing unmethylated cpg dinucleotide in combination with alum as adjuvants
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US6313268B1 (en) 1998-10-16 2001-11-06 Vivian Y. H. Hook Secretases related to Alzheimer's dementia
WO2000047618A2 (en) 1999-02-10 2000-08-17 Elan Pharmaceuticals, Inc. HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
CA2381755A1 (en) * 1999-08-26 2001-03-01 Vion Pharmaceuticals, Inc. Compositions and methods for delivery of an agent using attenuated salmonella containing phage
US20020052311A1 (en) * 1999-09-03 2002-05-02 Beka Solomon Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders
US20040013647A1 (en) * 1999-09-03 2004-01-22 Ramot At Tel-Aviv University Ltd. Methods and compositions for treating a plaque-forming disease
US6703015B1 (en) * 1999-09-03 2004-03-09 Ramot At Tel-Aviv University Ltd. Filamentous bacteriophage displaying an β-amyloid epitope
CA2349434A1 (en) * 1999-09-03 2001-03-15 Ramot University Authority For Applied Research & Industrial Development Ltd. Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
WO2001053457A2 (en) * 2000-01-21 2001-07-26 University Of Connecticut Health Center Vaccines against neurodegenerative disorders
AT349468T (en) * 2001-06-20 2007-01-15 Univ Ramot Multantigenic peptide contained multiple copies of epitopes from a deposit polypeptide and its use
AU2003226356A1 (en) * 2002-04-12 2003-10-27 Ramot At Tel Aviv University Ltd. Prevention of brain inflammation as a result of induced autoimmune response
GB0720912D0 (en) * 2007-10-25 2007-12-05 Univ Cardiff Monoclonal Anitbody for APP

Also Published As

Publication number Publication date
WO2003076455A2 (en) 2003-09-18
EP2292247A2 (en) 2011-03-09
AU2003225636A8 (en) 2003-09-22
US7854931B2 (en) 2010-12-21
US7494655B2 (en) 2009-02-24
CA2477675A1 (en) 2003-09-18
US20110070249A1 (en) 2011-03-24
EP1480666A4 (en) 2006-06-07
CA2477675C (en) 2013-05-21
EP1480666A2 (en) 2004-12-01
IL163812D0 (en) 2005-12-18
ES2392247T3 (en) 2012-12-07
IL212752A (en) 2014-01-30
AU2003225636A1 (en) 2003-09-22
JP2010248197A (en) 2010-11-04
EP1480666B1 (en) 2012-06-13
EP2292247A3 (en) 2011-10-05
IL163812A (en) 2011-06-30
US20060034855A1 (en) 2006-02-16
JP5717210B2 (en) 2015-05-13
JP2013181034A (en) 2013-09-12
US20070172484A1 (en) 2007-07-26
US8613928B2 (en) 2013-12-24
WO2003076455A3 (en) 2004-04-08
JP2005532276A (en) 2005-10-27

Similar Documents

Publication Publication Date Title
DE60314510D1 (en) Micromechanical switch, method of manufacture and application of the micromechanical switch
DE60322515D1 (en) Desaturasegene, of these encymes encoded and uses thereof
EP1338210B8 (en) Protein stabilizing agent
AU2003297681A1 (en) Abrasive webs and methods of making the same
EP1546112A4 (en) Imidazolopyridines and methods of making and using the same
AU2003234239A1 (en) Resection and anastomosis devices and methods
FI20041307A (en) Grinding products, with new structures, and grinding procedures
AU2003213606A1 (en) MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003209046A1 (en) Combined faucet and drain assembly
HRP20040618A2 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
AU2003213756A1 (en) Hydroimpedance pump
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
WO2004040000A9 (en) G protein coupled receptors and uses thereof
AT475377T (en) Humerusprothesis of the reversed construction
IL141665D0 (en) Ultrasonic positioning
AU2003265853A8 (en) Hedgehog antagonists, methods and uses related thereto
HK1076541A1 (en) Electro-osmotic pumps and micro-channels
EP1572131A4 (en) Antibody therapy
AU2003277108A1 (en) Subharmonic mixer
AU2003262857A1 (en) Selective feature activation
AU2003292164A1 (en) Osteotomy procedure
ZA200407902B (en) Tri-substituted hetreroaryls and methods of makingand using the same.
RU2005119640A (en) Multiple options of the meningokkkok protein nmbi1870
AU2002222459A1 (en) Ultrasonic positioning
EP1656095A4 (en) N,n-dihalogenated amino acids and derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees